NCT00661557View on ClinicalTrials.gov

Comparison of GSK134612 in Subjects Previously Vaccinated Against Meningococcal Disease Versus Non-vaccinated Subjects

PHASE2CompletedINTERVENTIONAL

Enrollment

271

Participants

Timeline

Start Date

May 19, 2008

Primary Completion Date

December 19, 2008

Study Completion Date

December 19, 2008

Conditions

Infections, Meningococcal

Interventions

BIOLOGICAL

Meningococcal vaccine GSK134612 (Nimenrix)

one dose, as intramuscular injection

Trial Locations (1)

1107-2020

GSK Investigational Site, Beirut

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY